HF 3119

as introduced - 92nd Legislature (2021 - 2022) Posted on 02/03/2022 03:30pm

A bill for an act
relating to health; modifying fees for patient enrollment in the medical cannabis
program; amending Minnesota Statutes 2020, section 152.35.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2020, section 152.35, is amended to read:

152.35 FEES; DEPOSIT OF REVENUE.

(a) The commissioner shall collect an enrollment fee of deleted text begin $200 deleted text end new text begin $40 new text end from patients enrolled
under deleted text begin this deleted text end section new text begin 152.27 new text end . deleted text begin If the patient provides evidence of receiving Social Security
disability insurance (SSDI), Supplemental Security Income (SSI), veterans disability, or
railroad disability payments, or being enrolled in medical assistance or MinnesotaCare, then
the fee shall be $50. For purposes of this section:
deleted text end

deleted text begin (1) a patient is considered to receive SSDI if the patient was receiving SSDI at the time
the patient was transitioned to retirement benefits by the United States Social Security
Administration; and
deleted text end

deleted text begin (2) veterans disability payments include VA dependency and indemnity compensation.
deleted text end

deleted text begin Unless a patient provides evidence of receiving payments from or participating in one of
the programs specifically listed in this paragraph, the commissioner of health must collect
the $200 enrollment fee from a patient to enroll the patient in the registry program. deleted text end The fees
shall be payable annually and are due on the anniversary date of the patient's enrollment.
The fee amount shall be deposited in the state treasury and credited to the state government
special revenue fund.

(b) The commissioner shall collect an application fee of $20,000 from each entity
submitting an application for registration as a medical cannabis manufacturer. Revenue
from the fee shall be deposited in the state treasury and credited to the state government
special revenue fund.

(c) The commissioner shall establish and collect an annual fee from a medical cannabis
manufacturer equal to the cost of regulating and inspecting the manufacturer in that year.
Revenue from the fee amount shall be deposited in the state treasury and credited to the
state government special revenue fund.

(d) A medical cannabis manufacturer may charge patients enrolled in the registry program
a reasonable fee for costs associated with the operations of the manufacturer. The
manufacturer may establish a sliding scale of patient fees based upon a patient's household
income and may accept private donations to reduce patient fees.

new text begin EFFECTIVE DATE. new text end

new text begin This section is effective July 1, 2022.
new text end